Earnings Call Intelligence Subscribe
Home › Call Sheets › ALGN › Q2'26
Call sheet · Q2'26

Align Technology (ALGN)

Q2'26 earnings call · held July 29, 2026 · compared with the Q1'26 call · management-credibility review
4/12
Disclosure score
2 high, 4 medium flags
Financial quality
Bottom line
The market will tout record clear‑aligner volume, but the real story is **financing and low‑priced scanner leases are quietly reshaping the profit engine** - they boost case starts now but erode gross margin and create a capacity bottleneck on scanner adoption. Management’s guidance hides the mix‑driven margin drag and offers no hard numbers on DSP, No‑AA, or lease revenue, leaving us with a **binding constraint of scanner capacity and financing‑driven margin compression**. If financing conversion lifts are lower than implied or lease mix accelerates, operating margin will miss the 100‑bp target and the stock could be over‑valued.

The 30-second version

  • FINANCING IS THE UNSEEN ENGINE OF Q2 GROWTH
  • OBVIOUS HEADLINE - RECORD CLEAR ALIGNER VOLUMES BUT MARGINS ARE DRAGGED BY MIX SHIFT
  • METRIC DISAPPEARANCE - NO CASE‑SHIPMENT GUIDANCE, NO DSO SHARE, NO DSO‑LEVEL UTILIZATION

What changed this quarter

MetricQ1'26Q2'26Change
Total Revenue$1.04 B (+6.2% YoY)Not disclosed (guidance $1.04‑$1.06 B, +3‑5% YoY)Guidance narrowed to +3‑5% YoY vs +6.2% prior
Clear Aligner Revenue$856 M (+7.4% YoY)Not disclosed (guidance: volume up mid‑single digits, ASP flat)ASP flat vs prior +1% YoY, volume growth guidance lower
Systems & Services Revenue$184.1 M (+1.0% YoY)Not disclosed (systems down 7% YoY at midpoint, offset by higher ASP)Revenue down 7% YoY
GAAP Operating Margin13.6% (Q1)Guidance ~16.4% (Q2) - appears higher but driven by lower Systems revenue & mixMargin guidance up 2.8 pts YoY
Non‑GAAP Operating Margin21.5% (Q1)Guidance ~21.5% (Q2) - flatFlat YoY
Free Cash Flow$120.3 MNot disclosed (no CFFO or CapEx numbers released)No visibility - red flag
Capital Expenditures$30.8 M$125‑$150 M FY guidance (no Q2 split)CapEx guidance 4‑5x Q1 level
Share Repurchase Commitment$200 M completed Q1$400‑$500 M FY target (including $133 M through Oct 2026)Additional $200‑$300 M buy‑back pressure on cash
DSP (Doctor Subscription Program) Touch‑up VolumeDouble‑digit YoY growth (Q1)Qualitative “strong traction” - no numbersMetric dropped from quantitative to narrative
No‑AA (Zero Refinement) AdoptionPilot in DSOs, early 2025 rollout“Broad rollout continues, modest impact this year” - no volume or revenue disclosedNo quantitative update

Accountability tracked

5 new promises made5 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full ALGN Q2'26 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.